<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE327nnn/GSE327288/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE327288</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Mimicking physiologically relevant environments in patient-derived tumor-immune models to target immunologically cold high-grade serous tumors</name><description>High-grade serous tumors are immunologically cold, characterized by limited immune cell infiltration and reduced clinical outcome, primarily due to hypoxia and extensive extracellular matrix remodeling that disrupt tumor-stromal-immune interactions. However, current experimental models fail to fully capture oxygen and matrix microenvironmental features, limiting progress in understanding tumor-immune dynamics and developing effective treatments. Here, we demonstrate that patient-derived tumor-immune models, mimicking physiologically relevant oxygen levels and extracellular matrix remodeling, recapitulate the hypoxia-induced stromal/matrix dysregulation, which associates with impaired immune infiltration, and enable dissecting targeted opportunities via TGF-β signaling. The models incorporate cancer cells co-cultured with cancer-associated fibroblasts within 3D matrices bioengineered using human plasma or grown on decellularized human ovarian extracellular matrices. Immune cells were either included within the 3D constructs as a multiculture to study tumor-immune interactions or challenged to infiltrate the matrices. By bioengineering physiologically relevant oxygen levels, we uncovered that intratumoral hypoxia acts as a friend and a foe, causing hypoxia-induced stromal-driven impaired immune infiltration but enhancing the activation and cytotoxicity of CD8+ T cells. We also showed that targeting TGF-β signaling reversed the hypoxia-induced stromal-driven impaired immune infiltration. These female patient-relevant models may aid the development of targeted therapies to turn immunologically cold tumors into hot ones.</description><dates><publication>2026/05/29</publication></dates><accession>GSE327288</accession><cross_references><GSM>GSM9652825</GSM><GSM>GSM9652826</GSM><GSM>GSM9652827</GSM><GSM>GSM9652823</GSM><GSM>GSM9652824</GSM><GPL>34284</GPL><GSE>327288</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>